Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: Evidence from the ICS-'BPH' study

British Journal of Urology

Volumn 80, Issue 5, 1997, Pages 712-721

  Donovan, J L ^a   Kay, H E ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Benign prostatic hyperplasia; Lower urinary tract symptoms; Quality of life; Questionnaire

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; URINARY TRACT DISEASE; ANXIETY; ATTITUDE TO HEALTH; DRINKING BEHAVIOR; MICTURITION DISORDER; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SENSITIVITY AND SPECIFICITY; STANDARD;

AGED; ANXIETY; ATTITUDE TO HEALTH; DRINKING BEHAVIOR; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; URINATION DISORDERS;

EID: 0031400391     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1997.00461.x     Document Type: Article

References (32)

1. Donovan JL, Frankel SJ, Nanchahal K, Coast J, Williams MH. Prostatectomy for benign prostatic hyperplasia. In Stevens A, Raftery J eds, Health Care Needs Assessment. Vol. 2. Oxford: Radcliffe Medical Press, 1994: 140-201
2. Abrams P. New words for old: lower urinary tract symptoms for 'prostatism.' (Editorial). Br Med J 1994; 308: 929-30
3. McConnell JD, Barry MJ, Bruskewitz RC et al. eds. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Clinical Practice Guideline. Rockville, Maryland. US Department of Health and Human Services. Agency for Health Care Policy and Research, 1994
4. Cockett ATK, Khoury S, Aso Y et al. eds. Proceedings of the Second WHO International Consultation on Benign Prostatic Hyperplasia. Jersey: Scientific Communication International Ltd, 1993
5. Cockett ATK, Khoury S, Aso Y et al. eds. Proceedings of the Third WHO International Consultation on BPH. Jersey: Scientific Communication International Ltd. 1995
6. Fallowfield L. The Quality of Life - The Missing Measurement in Health Care. London: Souvenir Press Ltd, 1990
7. Ware JE. SF-36 Health Survey Manual and Interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Centre, 1993
8. Brazier JE, Harper R, Jones NMB et al. Validating the SF-36 health survey questionnaire - new outcome measure for primary care. Br Med J 1992; 305: 160-4
9. The EuroQol Group. EuroQol - a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199-208
10. Barry MJ, Fowler FJ, O'Leary MP et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-57
11. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991; 138: 59-62
12. Peters TJ, Donovan JL, Kay HE et al. The ICS-'BPH' study: the bothersomeness of urinary symptoms. J Urol 1997; 157: 885-9
13. Barry M, Fowler F, O'Leary M, Bruskewitz R, Holtgrewe H, Mebust W. Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 1995; 334: AS145-AS155
14. Lukacs B, Leplege A, Thibault P, Jardin A. Development, validation and application of a BPH - specific health related quality of life questionnaire. In: Cockett ATK, Koury S, Aso Y et al. eds, Proceedings of the Third WHO International Consultation on BPH. Jersey: Scientific International, 1996: 277-80
15. Tsang KK, Garraway WM. Impact of benign prostatic hyperplasia on general well-being of men. Prostate 1993; 23: 1-7
16. Sagnier P, MacFarlene G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995; 153: 669-73
17. Anon. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. J Urol 1993; 150: 1696-1700
18. Emberton M, Neal D, Black N et al. The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996; 77: 233-47
19. Fowler FJ Jr, Barry MJ. Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index. Eur Urol 1993; 24 (Suppl 1): 24-7
20. Garraway WM, Kirby RS. Benign prostatic hyperplasia effects on quality of life and impact on treatment decisions. Urology 1994; 44: 629-36
21. Venrooij G, Boon T, De Gier R. International prostate symptom score and quality of life assessment versus urodynamic parameters in men with benign prostatic hyperplasia symptoms. J Urol 1994; 153: 1516-9
22. Abrams P, Donovan JL, de la Rosette JJMCH, Schäfer W, ICS-'BPH' Study Group. International continence society 'benign prostatic hyperplasia' study: background, aims and methodology. Neurourol Urodynam 1997; 16: 79-91
23. Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P. Urinary symptoms in the community: how bothersome are they? Br J Urol 1994; 74: 551-5
24. Donovan JL, Abrams P, Peters TJ et al. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1996; 77: 554-62
25. Streiner DL, Norman GR. Health Measurement Scales. Oxford: OUP, 1989
26. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford: Blackwell Science, 1987
27. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i: 307-10
28. Hald T, Elbadawi A, Horn T, Homma Y, Keuppens F. The effects of obstruction and ageing on the function of the lower urinary tract. In Cockett ATK, Khoury S, Aso Y, Chatelain C eds, Proceedings of the Second WHO International Consultation on BPH. Jersey: Scientific Communication International, 1993: 85-128
29. Bosch JLHR, Hop WCJ, Kirkels WJ, Schroder FH. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995; 75: 622-30
30. de la Rosette JMCH, Witjes WPJ, Schafer W et al. The relationships between lower urinary tract symptoms and bladder outlet obstruction - results from the ICS-'BPH' study. Neurourol Urodynam (submitted)
31. Bowling A. Measuring Disease. Buckingham: Open University Press, 1995
32. Wilkin D, Hallam L, Doggett M-A. Measures of Need and Outcome for Primary Health Care. Oxford: OUP, 1992